Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study

In Haiti, 22 communes still require mass drug administration (MDA) to eliminate lymphatic filariasis (LF) as a public health problem. Several clinical trials have shown that a single oral dose of ivermectin (IVM), diethylcarbamazine (DEC) and albendazole (ALB) (IDA) is more effective than DEC plus A...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubray, Christine L., Sircar, Anita D., Beau de Rochars, Valery Madsen, Bogus, Joshua, Direny, Abdel N., Ernest, Jean Romuald, Fayette, Carl R., Goss, Charles W., Hast, Marisa, O’Brian, Kobie, Pavilus, Guy Emmanuel, Sabin, Daniel Frantz, Wiegand, Ryan E., Weil, Gary J., Lemoine, Jean Frantz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302858/
https://www.ncbi.nlm.nih.gov/pubmed/32511226
http://dx.doi.org/10.1371/journal.pntd.0008298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302858/
https://www.ncbi.nlm.nih.gov/pubmed/32511226
http://dx.doi.org/10.1371/journal.pntd.0008298

Ejemplares similares